Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis

Folkman, 1995, Angiogenesis in cancer, vascular rheumatoid and other diseases, Nature Med, 1, 27, 10.1038/nm0195-27

Pluda, 1997, Tumor associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies, Semin Oncol, 24, 203

Lee, 1997, Angiogenesis and inflammation in invasive carcinoma of the breast, J Clin Pathol, 50, 669, 10.1136/jcp.50.8.669

Vartanian, 1994, Correlation of intratumoral endothelial cell proliferation with microvessel density, tumor angiogenesis, and tumor cell proliferation in breast carcinoma, Am J Pathol, 144, 1188

Burgess, 1989, The heparin binding (fibroblast) growth factor family of proteins, Annu Rev Biochem, 58, 575, 10.1146/annurev.bi.58.070189.003043

Conn, 1990, Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet derived growth factor, Proc Natl Acad Sci USA, 87, 2628, 10.1073/pnas.87.7.2628

Muller, 1987, Inhibitory action of transforming growth factor β on endothelial cells, Proc Natl Acad Sci USA, 84, 5600, 10.1073/pnas.84.16.5600

Roberts, 1989, Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-β1, Am Rev Respir Dis, 140, 1126, 10.1164/ajrccm/140.4.1126

Pepper, 1990, Transforming growth factor β modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro, J Cell Biol, 111, 743, 10.1083/jcb.111.2.743

Folkman, 1987, Angiogenic factors, Science, 235, 442, 10.1126/science.2432664

Meininger, 1992, Mast cells and angiogenesis, Semin Cancer Biol, 3, 73

O'Reilly, 1994, Angiostatin: a novel angiogenesis inhibitor that mediate the suppression of metastases by Lewis lung carcinoma, Cell, 79, 315, 10.1016/0092-8674(94)90200-3

Gately, 1996, Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin, Cancer Res, 56, 4887

Good, 1990, A tumor suppressor dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin, Proc Natl Acad Sci USA, 87, 6624, 10.1073/pnas.87.17.6624

DiPietro, 1993, Angiogenic macrophages produce the angiogenic inhibitory thrombospondin 1, Am J Pathol, 43, 678

O'Reilly, 1997, Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell, 88, 277, 10.1016/S0092-8674(00)81848-6

Polverini, 1989, Macrophage induced angiogenesis: a review, Cytokines, 1, 54

DiPietro, 1993, Role of macrophage in the positive and negative regulation of wound neovascularization, Behring Inst Mitt, 92, 238

Folkman, 1992, The role angiogenesis in tumor growth, Semin Cancer Biol, 3, 65

Iruela-Arispe, 1997, Angiogenesis: a dynamic balance of simulators and inhibitors, Thromb Haemost, 78, 672, 10.1055/s-0038-1657610

Nguyen, 1996, A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis, Nature, 365, 267, 10.1038/365267a0

Koch, 1995, Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule 1, Nature, 376, 517, 10.1038/376517a0

Morbidelli, 1998, Endothelial cell migration is induced by soluble P-selectin, Life Sci, 62, 7

Nguyen, 1996, Novel synthetic analogs of sialyl Lewis X can inhibit angiogenesis in vitro and in vivo, Biochem Biophys Res Commun, 228, 716, 10.1006/bbrc.1996.1722

Banks, 1993, Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies, Br J Cancer, 68, 122, 10.1038/bjc.1993.298

Wittig, 1996, Elevated serum E-selectin in patients with liver metastases of colorectal cancer, Eur J Cancer, 32A, 1215, 10.1016/0959-8049(96)00086-X

Matsuura, 1997, Increased concentrations of soluble E-selectin in the sera of breast cancer patients, Anticancer Res, 17, 1367

Hebbar, 1998, The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer, Clin Cancer Res, 4, 373

Hartwell, 1998, Angiogenesis in P- and E-selectin-deficient mice, Microcirculation, 5, 173

Gerritsen, 1996, Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro, Lab Invest, 75, 175

Nguyen, 1992, 1-Deoxymannojirimycin inhibits capillary tube formation in vitro analysis of linked oligosaccharides in bovine capillary endothelial cells, J Biol Chem, 267, 26157, 10.1016/S0021-9258(18)35730-2

Barondes, 1994, Galectins—a family of animal β-galactoside-binding lectins, Cell, 76, 597, 10.1016/0092-8674(94)90498-7

Barondes, 1994, Galectins, structure, and function of a large family of animal lectins, J Biol Chem, 269, 20807, 10.1016/S0021-9258(17)31891-4

Akahani, 1997, Galectin-3, a novel anti-apoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family, Cancer Res, 57, 5272

Lotan, 1994, Expression of a 31 kDa lactose-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas, Int J Cancer, 56, 474, 10.1002/ijc.2910560404

Shoeppner, 1995, Expression of an endogenous galactoside-binding lectin correlates with neoplastic progression in the colon, Cancer, 75, 2818, 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#

Xu, 1995, Differential expression of galectin-1 and galectin-3 in thyroid tumors: potential diagnostic implications, Am J Pathol, 147, 815

Nangia-Makker, 1995, Induction of tumorigenicity by gal-3 in a non-tumorigenic human breast carcinoma cell line, Int J Oncol, 7, 1079

Gillenwater, 1990, Expression of galectins in head and neck squamous cell carcinoma, Head Neck, 18, 422, 10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.0.CO;2-7

Fernandez, 1997, Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue, J Pathol, 181, 80, 10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E

Bresalier, 1998, Metastasis of human colon cancer is altered by modifying expression of the β galactoside-binding protein galectin-3, Gastroenterology, 115, 287, 10.1016/S0016-5085(98)70195-7

Nangia-Makker, 1998, Galectin-3 and L1 retrotransposons in human breast carcinomas, Breast Cancer Res Treat, 49, 171, 10.1023/A:1005913810250

Ochieng, 1993, Structure function relationship of a recombinant human galactoside-binding protein, Biochemistry, 32, 4455, 10.1021/bi00067a038

Platt, 1992, Modulation of the lung colonization of B16–F1 melanoma cells by citrus pectin, J Natl Cancer Inst, 84, 438, 10.1093/jnci/84.6.438

Bauer, 1992, In vitro model of angiogenesis using a human endothelium derived permanent cell line contributions of induced gene expression, G proteins, and integrins, J Cell Physiol, 153, 437, 10.1002/jcp.1041530302

Scatchard, 1949, The attractions of proteins for small molecules and ions, Ann NY Acad Sci, 51, 660, 10.1111/j.1749-6632.1949.tb27297.x

Passaniti, 1992, A simple quantitative method for assessing angiogenesis and anti-angiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor, Lab Invest, 67, 519

Inohara, 1994, Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions, Glycoconj J, 11, 527, 10.1007/BF00731303

Pienta, 1995, Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin, J Natl Cancer Inst, 87, 348, 10.1093/jnci/87.5.348

Bussolino, 1997, Molecular mechanisms of blood vessel formation, Trends Biochem Sci, 22, 251, 10.1016/S0968-0004(97)01074-8

Polverini, 1995, The pathophysiology of angiogenesis, Crit Rev Oral Biol Med, 6, 230, 10.1177/10454411950060030501

Polverini, 1984, Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages, Lab Invest, 51, 635

Polverini, 1996, How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases, Eur J Cancer, 32A, 2430, 10.1016/S0959-8049(96)00386-3

Leek, 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, Cancer Res, 56, 4625

Nangia-Makker, 1993, Regulation of the expression of galactoside-binding lectin during human monocytic differentiation, Cancer Res, 53, 5033

Liu, 1995, Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages, Am J Pathol, 147, 1016

Carlson, 1998, Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils, Blood, 91, 3430, 10.1182/blood.V91.9.3430

Sato, 1992, Binding of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin, J Biol Chem, 267, 6983, 10.1016/S0021-9258(19)50525-7

Warfield, 1997, Adhesion of human breast carcinoma to extracellular matrix proteins is regulated by galectin-3, Invasion Metastasis, 17, 101

Kern, 1996, The role of angiogenic growth factors in breast cancer progression, Cancer Metastasis Rev, 15, 213, 10.1007/BF00437474

Enenstein, 1992, Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells, Exp Cell Res, 203, 499, 10.1016/0014-4827(92)90028-7

Bischoff, 1997, Cell adhesion and angiogenesis, J Clin Invest, 99, 373, 10.1172/JCI119168

Bach, 1998, VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels, Exp Cell Res, 238, 324, 10.1006/excr.1997.3844

Vlodavsky, 1987, Endothelial cell derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix, Proc Natl Acad Sci USA, 84, 2292, 10.1073/pnas.84.8.2292

Kjellen, 1991, Proteoglycans: structure and interactions, Annu Rev Biochem, 60, 443, 10.1146/annurev.bi.60.070191.002303

Vlodavsky, 1996, Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor, Cancer Metastasis Rev, 15, 177, 10.1007/BF00437470